So, a buy out could happen. But, realistically, only if the business concerns are seperated. What people seem to be failing to understand, and get their knickers in a twist about, is that there is still no clear delineation between concerns of this stock.
A med tech company won't, likely, buy a med tech company that comes bundled with a vaccine and Regen division unless they were specifically looking to move into either sector and those arms looked valuable. Same goes for the others. Especially true when there's no visible horizon for vaccines ATM.
For what it's worth, I'm still positive, generally, about the co over the next 6 months. I just think there's a better strategy to be had here. And no one has said anything that could convince me otherwise.
So, a buy out could happen. But, realistically, only if the...
-
- There are more pages in this discussion • 407 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.35 |
Change
0.150(0.87%) |
Mkt cap ! $333.5M | |||
| Open | High | Low | Value | Volume |
| $17.19 | $17.39 | $16.90 | $350.7K | 20.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 66 | $17.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.50 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |